Projects per year
Personal profile
Biography
Position
Professor of Medicinal Chemistry
Scientific Director Monash Fragment-Based Drug Design Platform
Medicinal Chemistry
Monash Institute of Pharmaceutical Sciences
Research interests
Fragment-based drug design
Structure-based design of novel anti-microbial agents
Analysis of protein-ligand interactions
Protein structure determination and structural biology
Monash teaching commitment
- Spectrometric identification of small molecules
- Drug-protein interactions
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2001 2020
Understanding the Cellular Pathways of Nuclear Receptor Activation
Porter, C., Bunnett, N., Halls, M. & Scanlon, M.
Australian Research Council (ARC), Monash University
1/01/15 → 1/12/19
Project: Research
Melbourne Biomolecular NMR Network
Stone, M., Bottomley, S., Gooley, P., Langford, S., Reynolds, E., Scammells, P., Scanlon, M., Separovic, F., Tuck, K., Whisstock, J. & Wilce, J.
Australian Research Council (ARC), The University of Melbourne, Monash University
1/01/09 → …
Project: Research
Compounds Australia - Enabling the Next Phase of Australian Drug Discovery
Poulsen, S., Martin, J. L., Avery, V. M., Quinn, R. J., Baell, J., Scanlon, M., Booker, G. W., Abell, A., Wang, S., Karuso, P., Guillemin, G. A., Smith, J. A., Ryan, J. H. & Peat, T. S.
Monash University – Internal University Contribution, Monash University – Internal School Contribution
10/03/17 → 9/03/18
Project: Research
Fragment-based design of inhibitors of the essential Neisserial enzyme DsbD
Scanlon, M., Devine, S., Heras, B. & Kahler, C.
British Society for Antimicrobial Chemotherapy
16/05/16 → 31/12/17
Project: Research
Research Output 1991 2019
A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists
Patil, R., Mohanty, B., Liu, B., Chandrashekaran, I. R., Headey, S. J., Williams, M. L., Clements, C. S., Ilyichova, O., Doak, B. C., Genissel, P., Weaver, R., Vuillard, L., Halls, M. L., Porter, C. J. H. & Scanlon, M. J., 8 Mar 2019, In : Journal of Biological Chemistry. 294, 10, p. 3720-3734 15 p.Research output: Contribution to journal › Article › Research › peer-review
Identification of the Binding Site of Apical Membrane Antigen 1 (AMA1) Inhibitors Using a Paramagnetic Probe
Akter, M., Drinkwater, N., Devine, S. M., Drew, S. C., Krishnarjuna, B., Debono, C. O., Wang, G., Scanlon, M. J., Scammells, P. J., McGowan, S., MacRaild, C. A. & Norton, R. S., 5 Mar 2019, In : ChemMedChem. 14, 5, p. 603-612 10 p.Research output: Contribution to journal › Article › Research › peer-review
Cyclic Hexapeptide Mimics of the LEDGF Integrase Recognition Loop in Complex with HIV-1 Integrase
Northfield, S. E., Wielens, J., Headey, S. J., Williams-Noonan, B. J., Mulcair, M., Scanlon, M., Parker, M. W., Thompson, P. E. & Chalmers, D. K., 10 Aug 2018, In : ChemMedChem. 13, 15, p. 1555-1565 11 p.Research output: Contribution to journal › Article › Research › peer-review
Dietary docosahexaenoic acid supplementation enhances expression of fatty acid-binding protein 5 at the blood–brain barrier and brain docosahexaenoic acid levels
Pan, Y., Morris, E. R., Scanlon, M. J., Marriott, P. J., Porter, C. J. H. & Nicolazzo, J. A., 1 Jul 2018, In : Journal of Neurochemistry. 146, 2, p. 186-197 12 p.Research output: Contribution to journal › Article › Research › peer-review
Fatty Acid-Binding Protein 5 Mediates the Uptake of Fatty Acids, but not Drugs, Into Human Brain Endothelial Cells
Lee, G. S., Pan, Y., Scanlon, M. J., Porter, C. J. H. & Nicolazzo, J. A., Apr 2018, In : Journal of Pharmaceutical Sciences. 107, 4, p. 1185-1193 9 p.Research output: Contribution to journal › Article › Research › peer-review
Activities 2013 2013
- 1 Submissions to industry or govt committees, commissions and inquiries
Medicinal Chemistry
Martin Scanlon (Member)2 Sep 2013
Activity: External Academic Engagement › Submissions to industry or govt committees, commissions and inquiries